Arkolith/Insider Trading/AKUS/Form 4

McKenna Michael John

Chief Medical OfficerAkouos, Inc. (AKUS) · full profile →Form 4 · filed Dec 2, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2022Tender(U)82K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2022Disposed to issuer(D)90K——0
Dec 1, 2022Disposed to issuer(D)24K——0
Dec 1, 2022Disposed to issuer(D)56K——0
Dec 1, 2022Disposed to issuer(D)73K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-124134) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML